tiprankstipranks
Trending News
More News >
2seventy bio Delays Yearly Report Filing
PremiumCompany Announcements2seventy bio Delays Yearly Report Filing
3M ago
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
Premium
The Fly
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
3M ago
Hold Rating Amidst Favorable Acquisition Terms and Competitive Pressures for 2seventy bio
Premium
Ratings
Hold Rating Amidst Favorable Acquisition Terms and Competitive Pressures for 2seventy bio
3M ago
2seventy Bio reports preliminary FY25 Abecma revenue $242M
PremiumThe Fly2seventy Bio reports preliminary FY25 Abecma revenue $242M
4M ago
Regeneron pays $1M milestone payment to Medigene
Premium
The Fly
Regeneron pays $1M milestone payment to Medigene
6M ago
2seventy bio Reports Strong Growth in Abecma Sales
Premium
Company Announcements
2seventy bio Reports Strong Growth in Abecma Sales
7M ago
2seventy Bio to discontinue enrollment in Phase 3 KarMMa-9 study of Abecma
PremiumThe Fly2seventy Bio to discontinue enrollment in Phase 3 KarMMa-9 study of Abecma
9M ago
2seventy Bio sees Q3 Abecma U.S. revenue growth ~ 30% vs. Q2
Premium
The Fly
2seventy Bio sees Q3 Abecma U.S. revenue growth ~ 30% vs. Q2
9M ago
2seventy Bio lowers net cash spend range to $40M-60M for FY24
Premium
The Fly
2seventy Bio lowers net cash spend range to $40M-60M for FY24
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100